Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: Species/dose comparisons and possible mechanism

Fundamental and Applied Toxicology

Volumn 34, Issue 2, 1996, Pages 265-275

  Santostefano, Michael J ^a   Johnson, Krista L ^b   Whisnant, Nicole A ^a   Richardson, Vicki M ^c   Devito, Michael J ^c   Diliberto, Janet J ^c   Birnbaum, Linda S ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b ALION SCIENCE AND TECHNOLOGY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; ENZYME BINDING; ENZYME INDUCTION; FEMALE; ISOTOPE LABELING; KIDNEY; LIVER; LIVER MICROSOME; LUNG; MICROSOME; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TISSUE DISTRIBUTION;

EID: 26844560562     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0196     Document Type: Article

References (49)

1. Abraham, K., Krowke, R., and Neubert, D. (1988). Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch. Toxicol. 62, 359-368.
2. 14C]tetrachlorodibenzo-p-dioxin in rats. Food Cosmet. Toxicol. 13, 501-505.
3. Andersen, M. E., Mills, J. J., Gargas, M. L., Kedderis, L., Birnbaum, L. S., Neubert, D., and Greenlee, W. F. (1993). Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. Risk Anal. 13, 25-36.
4. Birnbaum, L. S. (1994). The mechanism of dioxin toxicity: Relationship to risk assessment. Environ. Health Perspect. 102, 157-167.
5. Birnbaum, L. S., and Couture, L. A. (1986). Disposition of octachlorodienzo-p-dioxin (OCDD) in male rats. Toxicol. Appl. Pharmacol. 93, 22-30.
6. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Buckley-Kedderis, L., Diliberto, J. J., Linko, P., Goldstein, J. A., and Birnbaum, L. S. (1991a). Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: Biliary excretion and induction of cytochromes CYP1A1 and CYP1A2. Toxicol. Appl. Pharmacol. 111, 163-172.
8. Buckley-Kedderis, L. B., Diliberto, J. J., and Birnbaum, L. S. (1991b). Disposition and excretion of intravenous 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in rats. Toxicol. Appl. Pharmacol. 108, 397-406.
9. Buckley-Kedderis, L. B., Andersen, M. E., and Birnbaum, L. S. (1993). Effect of dose, time and pretreatment on the biliary excretion and distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Fundam. Appl. Toxicol. 121, 87-98.
10. Chaloupka, K., Steinberg, M., Santostefano, M., Rodriguez, L. V., Golstein, L., and Safe, S. (1995). Induction of Cyp1a-1 and Cyp1a-2 gene expression by reconstituted mixture of polynuclear aromtaic hydrocarbons in B6C3F1 mice. Chem.-Biol. Interact. 96, 207-221.
11. Couture, L. A., Elwell, M. R., and Birnbaum, L. S. (1988). Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin during a 13-week study. Toxicol. Appl. Pharmacol. 93, 31-46.
12. Curtis, L. R., Kerkvliet, N. L., Baecher-Steppan, L., and Carpenter, H. M. (1990). 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose. Fundam. Appl. Toxicol. 14, 523-531.
13. DeVito, M. J., and Birnbaum, L. S. (1995). The importance of pharmaokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam. Appl. Toxicol. 24, 145-148.
14. DeVito, M. J., Ma, X., Babish, J. G., Menache, M., and Birnbaum, L. S. (1994). Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124, 82-90.
15. DeVito, M. J., Ross, D. G., and Birnbaum, L. S. (1995). Disposition of PCDD/PCDF in mice. In Organohalogen Compounds (L. S. Birnbaum, R. Clement, M. Fingerhut, F. Matusumura, S. Ramamoorthy, L. Robertson, and S. Safe, Eds.), pp. 11-15. Edmonton, Alberta, Canada.
16. Diliberto, J. J., Akubue, P. I., Luebke, R. W., and Birnbaum, L. S. (1995). Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Toxicol. Appl. Pharmacol. 130, 197-208.
17. Favreau, L. V., and Pickett, C. B. (1991). Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. J. Biol. Chem. 266, 4556-4561.
18. Gasiewicz, T. A., Elferink, C. J., and Henry, E. C. (1991). Characterization of multiple forms of the Ah receptor: Recognition of a dioxin responsive enhancer involves heteromer formation. Biochemistry 30, 2909-2916.
19. Gasiewicz, T. A., and Neal, R. A. (1979). 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigs. Toxicol. Appl. Pharmacol. 51, 329-339.
20. Gasiewicz, T. A., and Rucci, G. (1984). Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. evidence for a homologous nature among various mammalian species. Mol. Pharmacol. 26, 90-98.
21. Gillner, M., Brittebo, E. B., Brandt, I., Soderkvist, P., Applegren, L. E., and Gustafsson, J. A. (1987). Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res. 47, 4150-4159.
22. Kociba, R. J., Keyes, D. G., Beyer, J. E., and Carreon, R. M. (1978a). Toxicologic studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Occup. Med. 4, 281-287.
23. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnis, R. P., Franson, L. E., Park, C. N., Bernard, S. D., Hummel, R. A., and Humiston, C. G. (1978b). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
24. Kociba, R. J., and Schweiz, B. A. (1982). Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Drug Metab. Rev. 13, 387-406.
25. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of bacteriophage T4. Nature (London) 277, 680-685.
26. Legraverend, C., Hannah, R. T., Eisen, H. J., Owens, I. S., Nebert, D. W., and Hankinson, O. (1982). Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones. J. Biol. Chem. 257, 6402-6407.
27. Leung, H. W., Ku, R. H., Paustenback, D. J., and Andersen, M. E. (1988). A physiological-based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Toxicol. Lett. 42, 15-28.
28. Luebke, R. W., Copeland, C. B., Andrews, D. L., Diliberto, J. J., Adubue, P. I., and Birnbaum, L. S. (1994). Effects of TCDD exposure on resistance to T. spiralis infection in mice. Toxicol. Appl. Pharmacol. 125, 7-16.
29. Norback, D. H., Engblom, J. F., and Allen, J. R. (1975). Tissue distribution and excretion of octachlorodibenzo-p-dioxin in the rat. Toxicol. Appl. Pharmacol. 32, 330-338.
30. Pineau, T., Fernandez-Salguero, P., Lee, S. S. T., McPhail, T., Ward, J. M., and Gonzalez, F. J. (1995). Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2. Proc. Natl. Acad. Sci. USA 92, 5134-5138.
31. Pohl, R. A., and Fouts, J. R. (1980). A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107, 150-155.
32. Poiger, H., Pluess, N., and Buser, H. R. (1989). The metabolism of selected PCDFs in the rat. Chemosphere 18, 259-264.
33. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
34. 125I]2-Iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: Characterization and identification. Mol. Pharmacol. 36, 113-120.
35. 125I] 2-iodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonists for the Ah receptor. Mol. Pharmacol. 36, 121-127.
36. Rushmore, T. H., and Pickett, C. B. (1990). Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265, 14648-14653.
37. Safe, S. H. (1986). Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26, 371-379.
38. Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jeffcoate, C. R. (1994). Mouse cytochrome P-450EF, representative of a new 1B subfamily of the cytochrome P-450s. J. Biol. Chem. 269, 14905-14911.
39. Shen, E. S., and Olson, J. R. (1987). Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of TCDD. Drug. Metab. Dispos. 15, 653-660.
40. Smialowicz, R. J., Riddle, M. M., Williams, W. C., and Diliberto, J. J. (1994). Comparison of the immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice and rats. Toxicol. Appl. Pharmacol. 124, 248-256.
41. Telakowski-Hopkins, C. A., King, R. G., and Pickett, C. B. (1988). Glutathione S-transferase Ya subunit gene: Identification of regulatory elements required for basal level and inducible expression. Proc. Natl. Acad. Sci. USA 85, 1000-1004.
42. Thoma, H., Mucke, W., and Kauert, G. (1990). Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver. Chemosphere 20, 433-442.
43. Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
44. Tuteja, N., Gonzalez, F. J., and Nebert, D. W. (1985). Developmental and tissue differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes. Dev. Biol. 112, 177-184.
45. van Birgelen, A. P. J. M., DeVito, M. J., Akins, J. M., Ross, D. G., Diliberto, J. J., and Birnbaum, L. S. (1996). Relative potencies of polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls derived from hepatic porphyrin accumulation in mice. Toxicol. Appl. Pharmacol. 138, 98-109.
46. Voorman, R., and Aust, S. D. (1987). Specific binding of polyhalogenated and aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol. Appl. Pharmacol. 90, 69-78.
47. Voorman, R., and Aust, S. D. (1989). TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is a tight binding inhibitor of cytochrome P-450d. J. Biochem. Toxicol. 4, 105-109.
48. Yoshimura, H., Kuroki, J., and Koga, N. (1987). Unique features of subcellular distribution of 2,3,4,7,8-pentachlorodibenzofuran in rat liver. Chemosphere 16, 1695-1700.
49. Yoshimura, H., Kuroki, J., Koga, N., Kuroki, H., Masuda, Y., Fukasaku, N., and Hasegawa, M. (1984). High accumulation of 2,3,4,7,8-pentachlorodibenzofuran to hepatic microsomes of rats. J. Pharmacodyn. 7, 414-419.